Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release May 30 2024

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-may-30-2024-10

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 30, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg.".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases